This case report describes the perioperative course of a patient undergoing emergency repair of acute type A thoracic aortic dissection. Andexanet alfa was administered intraoperatively to obtain a dry operative field for right axillary artery exposure and cannulation. Andexanet alfa-induced heparin resistance resulted in cardiopulmonary bypass circuit and pericardial thrombosis requiring more than 400,000 units of unfractionated heparin and antithrombin III to overcome. Postoperatively, excessive chest tube output was observed secondary to protracted heparin rebound requiring continuous dosing of protamine. This case demonstrates the significant challenging perioperative, not just intraoperative, hazards associated with intraoperative andexanet alfa use during emergency cardiac surgery with cardiopulmonary bypass.

Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest / Gikandi, A.; Connors, J. M.; Nabzdyk, C. G.; Zenati, M. A.. - In: PERFUSION-UK. - ISSN 0267-6591. - 40:4(2025), pp. 1045-1048. [10.1177/02676591241268395]

Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest

Zenati M. A.
Ultimo
2025-01-01

Abstract

This case report describes the perioperative course of a patient undergoing emergency repair of acute type A thoracic aortic dissection. Andexanet alfa was administered intraoperatively to obtain a dry operative field for right axillary artery exposure and cannulation. Andexanet alfa-induced heparin resistance resulted in cardiopulmonary bypass circuit and pericardial thrombosis requiring more than 400,000 units of unfractionated heparin and antithrombin III to overcome. Postoperatively, excessive chest tube output was observed secondary to protracted heparin rebound requiring continuous dosing of protamine. This case demonstrates the significant challenging perioperative, not just intraoperative, hazards associated with intraoperative andexanet alfa use during emergency cardiac surgery with cardiopulmonary bypass.
2025
Philadelphia, PA , USA
SAGE Publications Ltd
Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest / Gikandi, A.; Connors, J. M.; Nabzdyk, C. G.; Zenati, M. A.. - In: PERFUSION-UK. - ISSN 0267-6591. - 40:4(2025), pp. 1045-1048. [10.1177/02676591241268395]
Gikandi, A.; Connors, J. M.; Nabzdyk, C. G.; Zenati, M. A.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/472431
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex 0
social impact